Costs of radium-223 and the pharmacy preparation 177 Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitals.
Sara W QuistJeroen H J PaulissenD N J WyndaeleJames NagarajahRoel D FreriksPublished in: Journal of medical economics (2023)
Lu-PSMA-I&T. The detailed overview of the costs associated with radiopharmaceutical treatment provided by this study is relevant for both hospitals and healthcare insurers.